Key facts
- This page summarizes Thomas R. Kuhn's Form 4 filing for Anterix Inc. (ATEX).
- 8 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 26 Aug 2026, 16:46.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Sale
Options Exercise
Sale
Sale
Sale
Sale
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Footnote F1
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer's Common Stock. The RSU vests in full on the earlier of: (i) May 20, 2027, and (ii) the Issuer's next annual stockholder meeting.
Footnote F2
These shares of Common Stock were automatically sold in a non-discretionary transaction to cover tax withholding obligations upon the settlement of certain time-based RSU awards.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.67 to $88.66, inclusive. The Reporting Person has provided to the Issuer and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnote F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.71 to $89.67, inclusive. The Reporting Person has provided to the Issuer and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnote F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.79 to $90.51, inclusive. The Reporting Person has provided to the Issuer and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnote F6
1/3rd of the option shares vest and become exercisable on January 2, 2025, with the remaining option shares vesting in two equal annual installments thereafter.